QuickView for vs. III (biogroup)

1. Prostate cancer LNCaP cells expressing PSF (SFPQ) or CTBP1-AS siRNA and treated with R-1881
2. Breast adenocarcinoma MCF7 cells treated with delta-2-troglitazone
3. Embryonic kidney HEK293 cells expressing MKL1 isoforms and induced Rho-actin-MKL1 pathway
4. Cystic fibrosis bronchial epithelial cells challenged with Pseudomonas aeruginosa
5. MCF7 cell profiles of tamoxifen-resistant and sensitive subclones exposed to tamoxifen and estrogen

There were no matches for vs. III

1. COLOR III Trial: Transanal vs Laparoscopic TME
2. TFPB vs QLB III in Infra-umbilical Pediatric Surgeries
3. Japanese P III vs Voglibose and Placebo
4. To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN
5. Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-…